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Abstract. The primary source of malaria surveillance data in Uganda is the Health Management Information System
(HMIS), which does not require laboratory confirmation of reported malaria cases. To improve data quality, an
enhanced inpatient malaria surveillance system (EIMSS) was implemented with emphasis on malaria testing of all
children admitted in select hospitals. Data were compared between the HMIS and the EIMSS at four hospitals over a
period of 12 months. After the implementation of the EIMSS, over 96% of admitted children under 5 years of age
underwent laboratory testing for malaria. The HMIS significantly overreported the proportion of children under 5 years
of age admitted with malaria (average absolute difference = 19%, range = 8–27% across the four hospitals) compared
with the EIMSS. To improve the quality of the HMIS data for malaria surveillance, the National Malaria Control
Program should, in addition to increasing malaria testing rates, focus on linking laboratory test results to reported
malaria cases.
Uganda has made significant efforts to reduce the burden
of malaria through scaling up of effective tools for malaria
control, notably long-lasting insecticide-treated nets, indoor
residual spraying of insecticides, treatment with artemisinin-
based combination therapies, and intermittent preventive
therapy in pregnancy.1 Despite progress in these efforts, there
is much work to be done to achieve the objective of a > 75%
decrease in the malaria admission rate by 2015.2,3
Demand for high-quality malaria surveillance data to mon-
itor progress and evaluate the effectiveness of interventions is
greater than ever before.4 However, malaria surveillance is
often limited by non-specific case definitions and imperfect
data collection tools and indicators.3,5 The Ugandan National
Malaria Control Program (NMCP) malaria surveillance relies
on Health Management Information System (HMIS) data
from monthly health facility summary forms. However, the
usefulness of the HMIS data is limited by incomplete or
delayed reporting, poor data quality, and lack of malaria-
specific data based on laboratory confirmation.6,7
To improve malaria surveillance in Uganda, the NMCP
working with the Uganda Malaria Surveillance Program
(UMSP) with support from the US President’s Malaria Initia-
tive implemented the enhanced inpatient malaria surveillance
system (EIMSS) at six public hospitals.8 This program collects
high-quality malaria data by emphasizing universal malaria
laboratory testing for all hospitalized children and collecting
and reporting laboratory-confirmed malaria cases using a
computerized patient database. The program is limited to
collection of data in the children’s wards of participating hos-
pitals. We evaluated the accuracy of the HMIS malaria data
by using the EIMSS data as the gold standard.
The EIMSS was set up from April of 2010 to June of 2011
in four government-run hospitals: Tororo, Apac, Mubende,
and Kambuga (Figure 1). Tororo, Apac, and Kambuga are
general hospitals providing basic inpatient health services.
Mubende was recently elevated to a regional referral hospital.
Tororo District Hospital and Mubende Regional Hospital are
in areas of high malaria endemicity (parasite rates in children
2–9 years old > 50%). Apac District Hospital is in an area that
was previously highly endemic but has become moderately
endemic (parasite rate = 30–50%) after the introduction of
indoor residual spraying of insecticide. Kambuga District
Hospital is in a highland area with relatively low endemicity
(parasite rate < 20%).
The EIMSS included (1) the use of a standardized structured
medical record form (MRF) for the documentation of patient
details (presenting symptoms and signs, laboratory test results,
treatment administered, diagnosis, and final outcome on dis-
charge); (2) laboratory testing for parasitemia using micros-
copy for all admitted children, regardless of presentation; and
(3) training and routine supervision of hospital staff as well as
supply of essential materials, like MRFs. Individual patient
information captured on MRFs was entered into an Epi
Info database (Centers for Disease Control and Prevention,
Atlanta, GA). To increase malaria testing rates at the sites,
the UMSP provided direct support to the laboratories in the
form of training of microscopists and supplying essential mate-
rials and reagents required for malaria microscopy.
Data were transmitted approximately 2 weeks after the end
of each month to a central location for cleaning, analysis,
and reporting. The reported results included total number
of admissions, number tested for malaria, and number of
laboratory-confirmed malaria cases. For the HMIS, data were
obtained from the HMIS monthly summary forms and included
total admissions and numbers of malaria cases (final diagnosis
of clinical malaria). Comparison between the EIMSS and the
HMIS was limited to the children under 5 years old age group,
because the EIMSS is limited to the children’s ward.
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The indicator of interest for the comparison between the
HMIS and the EIMSS was the proportion of children admit-
ted with malaria. For the HMIS, this indicator was calculated
using the number of children given a clinical diagnosis of
malaria as the numerator and the total number of admissions
as the denominator. For the EIMSS, the number of children
with laboratory-confirmed malaria was the numerator, and
the number of children tested for malaria was the denomina-
tor. Data from both systems were analyzed for 12 months
after the implementation of the EIMSS. For comparison pur-
poses, the HMIS data from the 12-month period before the
implementation of the EIMSS were also reviewed. Results
are presented for only four of six sites where the EIMSS was
introduced because of problems with the HMIS forms in two
hospitals: the forms were destroyed at one site (Kabale) and
not filled out at another site (Jinja) because of a staffing
shortage. The proportions of malaria cases admitted during a
12-month period after the start of the program at each site
were compared using the c2 test. Any P value < 0.05 was
considered statistically significant.
During the 12-month period after the implementation of the
EIMSS, the total numbers of admissions reported by the HMIS
and the EIMSS were similar in three hospitals (Apac,
Mubende, and Kambuga), but they were different at Tororo
Hospital (HMIS: 4,385 versus EIMSS: 5,571) (Table 1). The
proportion of admitted children who were laboratory-tested
ranged from 94% to 98% at the four hospitals after the EIMSS
implementation (Table 1). Through training, supply of essen-
tial reagents, and continuous supervision, the UMSP was able
to maintain high testing rates at all four hospitals. This achieve-
ment suggests that near-universal testing for malaria in the
inpatient setting is feasible beyond the sentinel sites.
The HMIS reported significantly greater numbers of malaria
cases and therefore, higher proportions of patients with malaria
diagnosis compared with the EIMSS at all four hospitals. This
is a reflection of the case definitions used by the two systems—
clinical versus laboratory-confirmed (Table 1): Tororo (85%
versus 62%, P < 0.001), Kambuga (52% versus 25%, P <
0.001), Mubende (54% versus 38%, P < 0.001), and Apac
(47% versus 39%, P < 0.001). The differences between the
two systems were relatively consistent month to month at two
of the sites (Tororo and Kambuga) but inconsistent at the two
other sites (Apac and Mubende) (Figure 2).
Interestingly, the HMIS reported a statistically significant
reduction in the proportion of children under 5 years of age
diagnosed with malaria at all four hospitals after the implemen-
tation of the EIMSS: Tororo (94% versus 85%, P < 0.001),
Kambuga (84% versus 52%, P < 0.001), Mubende (65% ver-
sus 54%, P < 0.001), and Apac (68% versus 47%, P < 0.001)
(Figure 2 and Table 1). Although these differences could have
Figure 1. Study sites. Parasite rate is based on the estimated proportion of children 2–9 years of age with a positive blood smear based on
cross-sectional surveys.
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been caused by real changes in the burden of malaria, these
decreases were more likely because of the greater use of labo-
ratory test results when making malaria diagnoses after the
implementation of the EIMSS.
There are several limitations to this study that could influ-
ence the interpretation of the results. First, the study was
conducted in hospitals serving as malaria sentinel sites, where
the quality of the HMIS could have been influenced by the
ongoing sentinel surveillance work. Second, we do not know
whether the quality of the HMIS at two sites not included in
the analysis was substantially different from the quality at the
other sites. Third, because the EIMSS is limited to children
under 5 years of age, we do not know about the performance
and the quality of data reporting for older age groups.
Despite these limitations, we show that the proportions of
children with malaria reported by the HMIS were statistically
significantly greater than those reported by the EIMSS. Most
of these differences are likely caused by the differences in
case definitions used by the HMIS and the EIMSS.3,9 Even
when malaria laboratory tests are performed, the HMIS is not
designed to link test results with diagnosis, which is a funda-
mental limitation of current HMIS malaria data. In addition,
the reliance of the HMIS on paper forms and manual tabula-
tion could contribute to observed differences.10
Malaria diagnosis based on clinical observation without
laboratory confirmation is a common practice in Uganda
for many reasons. First, until recently, the World Health
Organization recommended presumptive treatment of suspect
Figure 2. Trends in malaria admission rates 12 months before and 12 months after the start of an enhanced malaria surveillance program at
four public hospitals in Uganda. Vertical bars represent the month when the enhanced surveillance program started collecting data.
Table 1
Routine and enhanced surveillance reporting of pediatric malaria in four district hospitals in Uganda
Hospital Start date
Routine HMIS surveillance data
12-Month period before start date 12-Month period after start date Enhanced surveillance data (12-month period after start date)
Total
admissions
Number of
malaria cases*
(% total admissions)
Total
admissions
Number of
malaria cases*
(% total admissions)
Total
admissions
Number tested
(% total admissions)
Number of confirmed
malaria cases†
(% number tested)
Tororo Hospital April of 2010 5,526 5,214 (94) 4,385 3,747 (85) 5,657 5,571 (98) 3,459 (62)
Kambuga Hospital January of 2011 2,106 1,767 (84) 1,538 793 (52) 1,559 1,530 (98) 384 (25)
Mubende Hospital April of 2011 2,215 1,444 (65) 2,930 1,581 (54) 2,890 2,717 (94) 1,020 (38)
Apac Hospital June of 2011 2,115 1,429 (68) 1,925 904 (47) 2,110 1,927 (98) 754 (39)
Only data for children less than 5 years of age are included.
*Based on a clinical diagnosis of malaria.
†Laboratory confirmed (microscopy).
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malaria in endemic countries.11 Second, clinicians lack skills
and capacity to confirm alternate diagnosis. Third, health
workers continue to believe in the benefits of presumptive
diagnosis, even in the setting of negative test results.12,13 The
practice of diagnosing malaria without laboratory confirma-
tion coupled with the non-specific nature of this diagnosis
have resulted in the HMIS reporting cases that were not
actually malaria, which may consistently overreport the true
burden of malaria.14,15
As a result, evaluating the impact of interventions using the
HMIS data is likely to be problematic.16–18 For example, as
malaria diagnostics are scaled up in Uganda, decreases in the
number of malaria cases reported by the HMIS may be
misinterpreted as a reduction in the burden of malaria rather
than simply improvements in the accuracy of the diagnosis of
malaria.19 Our data suggest that, for the HMIS data to be
useful in monitoring malaria trends, there is urgent need to
increase the proportion of malaria diagnoses reported based
on laboratory confirmation and link the laboratory results to
reported malaria cases.20
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